Through our research, we can get a knowledge of the tumor suppressing role of PHGDH inhibitor CBR-5884 in epithelial ovarian cancer via regulating the ROS level and the downstream Wnt/β-catenin signaling pathway. This evidence concerns the gene PHGDH and neoplasm.